AP NEWS

Global Anti-Malarial Medicines Market 2018-2022 - Key Vendors Are F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer & Sun Pharmaceutical Industries - ResearchAndMarkets.com

October 1, 2018

DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Anti-Malarial Medicines Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The Global Anti-Malarial Medicines Market to grow at a CAGR of 4.76% during the period 2018-2022.

Global Anti-Malarial Medicines Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

According to the report, one driver influencing this market is the strong funding to eradicate malaria. Malaria is on the top of the eradication list of WHO and this is leading to strong funding initiatives for prevention and control of malaria. One trend affecting this market is the enhancement of POC diagnostics and biomarkers for malaria. The global anti-malarial medicines market has great potential for the use of innovative and better POC diagnostics for an effective control of malaria.

Further, the report states that one challenge affecting this market are the drug resistant pathogens. Multidrug resistant microbes are a major threat as they can change themselves to protect themselves from antimicrobial agents and that is affecting the growth of the industry.

Key vendors:

F. Hoffmann-La Roche GlaxoSmithKline Novartis Pfizer Sun Pharmaceutical Industries

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: MARKET SIZING

Market sizing 2017 Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY PRODUCT

Comparison by product Artemisinin compounds Quinolines and related compounds Other compounds Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview Landscape disruption

PART 15: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/xlrtt2/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005876/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/01/2018 01:46 PM/DISC: 10/01/2018 01:46 PM

http://www.businesswire.com/news/home/20181001005876/en

AP RADIO
Update hourly